跳至主要内容
临床试验/NCT06406049
NCT06406049
招募中
不适用

FINISHING HIV: An Ending the HIV Epidemic (EHE) Model for Latinx Integrating One-Stop-Shop Pre-Exposure Prophylaxis (PrEP) Services, a Social Network Support Program and a National Pharmacy Chain

University of Miami1 个研究点 分布在 1 个国家目标入组 624 人2024年11月8日

概览

阶段
不适用
干预措施
Control group-Standard Health Promotion
疾病 / 适应症
Hiv
发起方
University of Miami
入组人数
624
试验地点
1
主要终点
Number of participants that report using PrEP
状态
招募中
最后更新
12天前

概览

简要总结

This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.

注册库
clinicaltrials.gov
开始日期
2024年11月8日
结束日期
2030年5月31日
最后更新
12天前
研究类型
Interventional
研究设计
Parallel
性别
Male

研究者

责任方
Principal Investigator
主要研究者

Mariano Juan Kanamori Nishimura

Associate Professor

University of Miami

入排标准

入选标准

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Being 18 to 54 years of age
  • Being a cis-gender male
  • Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility
  • Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia)
  • Sex with a partner who is living with HIV
  • Sex without a condom with two or more partners whose HIV status were unknown
  • Injection drug use and sharing injection equipment
  • Self-reported status as HIV negative

排除标准

  • Display diminished capacity to consent because of:
  • An inability to provide informed consent (e.g., cognitive impairment)
  • Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to provide informed consent, as assessed by interviewers with Collaborative Institutional Training Initiative (CITI) Human Subjects Research and National Institutes of Health (NIH) Good Clinical Practice training
  • \<18 years old or \>54 years old
  • Self-reported living with HIV
  • Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
  • Refusal of HIV test
  • Identifies as Non-Latinx
  • Individuals enrolled in other PrEP initiation interventions
  • Individuals with an active PrEP prescription in the last 6-months (oral or injectable)

研究组 & 干预措施

I want "Yo Quiero" Control Group

Participants will receive the standard of care for up to 15-months

干预措施: Control group-Standard Health Promotion

Friend "Amigx" Social network intervention

Participant will receive a social network intervention for up to 15-months

干预措施: Social network intervention

结局指标

主要结局

Number of participants that report using PrEP

时间窗: Up to 12-months

PrEP initiation will be measured by analyzing the number of participants that initiate PrEP divided by the total number of participants

Number of Dried Blood Spot (DBS) tests that report PrEP use

时间窗: Up to 12-months

PrEP initiation will be measured by analyzing the number of DBS tests that report PrEP use divided by the total number of participants

Number of participants that bring a proof of PrEP prescription

时间窗: Up to 12-months

PrEP initiation will be measured by analyzing the number of participants that bring proof of a PrEP prescription divided by the total number of participants

次要结局

  • Number of Dried Blood Spot (DBS) tests that report adequate PrEP adherence(Up to 12-months)
  • PrEP knowledge measured by PrEP knowledge question(Up to 12-months)

研究点 (1)

Loading locations...

相似试验